• Home
  • Exhibitor Information and Registration

Winship Cancer Institute 2018 Melanoma Conference

Meeting Overview

This Winship Cancer Institute 2018 Melanoma Conference will serve as a valuable forum for the presentation and discussion of newly available data. Participants will be provided with an update on practice-changing data in a practical and multidisciplinary interactive format, fostering discussion and impacting clinical outcomes throughout the clinical course of patients with melanoma and other skin malignancies.

Agenda

Saturday, March 3, 2018
8.00 AM Breakfast/exhibit hall open

 
9.00 AM Opening remarks
Walter J. Curran, Jr, MD
David Lawson, MD

 
9.10 AM War on melanoma: Taking it to the streets with mole mapping cancer screening
Sancy Leachman, MD, PhD

 
9.40 AM Radiation for nonmelanoma skin cancers in the dermatologist’s office: A radiation oncologist’s (generally positive) perspective
Mohammad Khan, MD, PhD

 
10.05 AM Molecular characterization of stage I-III melanoma: How close are we to accurate prognostication and prediction?
John Seykora, MD

 
10.35 AM BREAK AND EXHIBIT VIEWING

 
10.55 AM More skin in the game: Multidisciplinary management of cutaneous adverse events of targeted and immunotherapeutic agents
Rajini Murthy, MD

 
11.20 AM Update on new AJCC Staging System for Melanoma: What are the changes and why?
Jeff Gershenwald, MD

 
11.35 AM Approach to the nodal basin: Should we just leave it alone?
Jeff Gershenwald, MD

 
11.50 AM Adjuvant therapy of melanoma: Beyond ipilimumab?
David Lawson, MD

 
12.15 PM LUNCH

 
1.00 PM Update on Merkel cell carcinoma and other nonmelanoma skin cancers: The times they are a-changing
Ragini Kudchadkar, MD

 
1.15 PM Update on uveal melanoma: At least a glimmer of light
Melinda Yushak, MD

 
1.30 PM Multidisciplinary approach to metastatic melanoma: Systemic therapy before surgery or instead of surgery?
Michael Lowe, MD

 
2.00 PM Management of melanoma brain metastases: Much more to think about
Hussein Tawbi, MD, PhD

 
2.30 PM BREAK

 
2.50 PM Molecular testing of metastatic melanoma: Which test(s), when, how to interpret
Melinda Yushak, MD

 
3.05 PM Optimization of the use of immunotherapy and targeted agents by aggressive management of noncutaneous adverse events
Ragini Kudchadkar, MD

 
3.25 PM Systemic therapy for metastatic melanoma: Decisions and sequencing
David Lawson, MD

 
3.50 PM Closing remarks
David Lawson, MD

 
4.00 PM Adjourn

 

Faculty

Chair

 
David Lawson, MD
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States

Winship Symposium Committee

 
Jack Arbiser, MD, PhD
Suephy Chen, MD, MS
Keith Delman, MD
Mohammad K. Khan, MD, PhD, DABR
Ragini Kudchadkar, MD
Michael Lowe, MD
Douglas C. Parker, MD
Melinda Yushak, MD

Faculty

 
Jeffrey Gershenwald, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas, United States

Mohammad Khan, MD, PhD
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States

Ragini Kudchadkar, MD
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States

Sancy Leachman, MD, PhD
Oregon Health Sciences University
Knight Cancer Institute
Portland, Oregon, United States

Michael Lowe, MD
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States

Rajini Murthy, MD
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States

John T. Seykora, MD, PhD
Perelman School of Medicine,
University of Pennsylvania
Philadelphia, Pennsylvania, United States

Hussein Tawbi, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas, United States

Melinda Yushak, MD
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States

Target Audience

This educational activity is specifically designed to meet the needs of dermatologists, medical, surgical, radiation oncologists, and other healthcare professionals involved in the treatment of patients with melanoma and other skin malignancies.

Learning Objectives

After successful completion of this educational activity, participants should be able to:
  • Describe best practices for diagnosis and risk assessment for melanoma, Merkel cell carcinoma, or uveal melanoma, including the appropriate use of molecular testing
  • Identify patients who should receive radiotherapy, either alone or in combination with other therapeutic modalities
  • Assess best practices for surgical management of metastatic melanoma
  • Evaluate the risks and benefits of novel treatment strategies for patients with melanoma, Merkel cell carcinoma, or uveal melanoma, as well as the practical utility of these approaches based on recent clinical data
  • Identify strategies to manage adverse events associated with novel systemic treatment options

Registration Fee Information


Registration Fees Before February 15 On or After February 15
Physician/PharmD/PhD $100 $150
Nurse/Nurse practioner/Physician assistant $50 $75
Fellows/Residents/Students No Fee* No Fee*
Pharmaceutical industry representative (non-exhibitor) $450 $450

*Registration/Cancellation Policy for Fellows, Residents, Students
Credit card information will be required for registration. Although there is no registration fee for fellows, residents, students, and lab techs, a $20 "no-show" fee will be charged if you register but fail to attend the meeting and have not canceled your registration. Cancellations will be accepted without incurring a fee, up to 10 PM on February 26, 2018.

Cancellation Policy
Cancellation requests made in writing and/or by email

  • Prior to February 15, 2018, will incur an administrative fee equal to 20% of your registration fee
  • From February 16 through February 28, 2018, will incur an administrative fee equal to 50% of your registration fee

No refunds will be made after February 28, 2018.

The registration fee includes all scientific sessions, continuing education credit, printed and/or electronic program materials, breakfast, refreshment breaks, lunch, and access to the exhibit area.

Exhibitor Information

$10,000 Gold Exhibitor Package includes:

  • 4 complimentary registrations
  • 2 complimentary (prime spot) table displays
  • Acknowledgement on rolling slides (during breaks)
  • Logo and company name sponsor signage on site
  • List of attendees

$5,000 Silver Exhibitor Package includes:

  • 2 complimentary registrations
  • 1 complimentary table display (high traffic area)
  • Acknowledgement on rolling slides (during breaks)
  • Company name on sponsor signage on site
  • List of attendees

$1,750 Bronze Exhibitor Package includes:

  • 1 complimentary registration
  • 1 complimentary table display
  • List of attendees

Additional representatives may attend for $450 each.


EXHIBITOR REGISTRATION

The name and email addresses of both representatives attending are required fields. Payment can be made via credit card or by noting that you will send a check.

Checks should be made payable to:
prIME Oncology, LLC (Tax ID #20-5392799)

Download Forms


Checks should be mailed to:
Attn: Lisa Willey
5901-C Peachtree Dunwoody Road NE
Suite 250
Atlanta, Georgia 30328

For questions or further information, please contact Lisa Willey, Lisa.Willey@prIMEoncology.org or 678.686.7751

Register Now
Register Now

Date And Location

Saturday, March 3, 2018
8.00 AM – 4.00 PM

Rollins Auditorium
Health Sciences Research Building (HRSB) on the Emory Campus
1760 Haygood Drive
Atlanta, Georgia 30322

PROVIDER

This activity is provided by prIME Oncology.

Continuing Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint providership of prIME Oncology and Winship Cancer Center of Emory University. prIME Oncology is accredited by the ACCME to provide continuing medical education for physicians.

ACCME Logo

prIME Oncology designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Support

This educational activity is supported by grants from Bristol-Myers Squibb and Novartis Oncology.

Options are available to organizations interested in supporting this conference. For more information, please contact Anne Rojas at Anne.Rojas@prIMEoncology.org.

For exhibit information, please contact Lisa Willey at Lisa.Willey@prIMEoncology.org

Winship Cancer Institute of Emory University would like to provide special recognition of Mrs Brenda Nease, whose generosity has provided the impetus and signature sponsorship for the Melanoma Conference.